Contribute to the Treatment of Gastroenterological Diseases through the Supply of Asacol, Entocort(domestic name: Zentacort) and Acofide

The Ethical Pharmaceuticals business undertakes operations focusing on the gastrointestinal field as a priority area. In Japan, we offer an extensive lineup of gastrointestinal drugs extending from the upper to the lower gastrointestinal tracts. In addition to Acofide, a first-in-class agent approved for the indication of functional dyspepsia, these include Asacol, a therapeutic agent for ulcerative colitis; Entocort (domestic name: Zentacort), a first-line therapy for Crohn’s disease; Acinon, an H2 receptor antagonist; Promac, a zinc containing anti-ulcerant; Visiclear, an oral bowel cleansing agent; and New Lecicarbon, a laxative.

Overseas, Swiss-based Tillotts Pharma, which became a group company in 2009, has established a worldwide sales network through sales subsidiaries and partner companies and is increasing its global presence. Asacol and Entocort, which Tillotts Pharma markets globally, are sold in over 60 countries around the world in Europe, North and South America, Africa, and Asia/Oceania.